Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia

This study has been completed.
Boehringer Ingelheim
Information provided by:
University Hospital, Caen Identifier:
First received: November 27, 2006
Last updated: October 27, 2010
Last verified: October 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: February 2006
  Estimated Primary Completion Date: No date given